Biologics Is Fastest Growing Segment Fueling The Growth Of Eosinophilic Esophagitis Market


https://www.coherentmarketinsights.com/market-insight/eosinophilic-esophagitis-market-4909
Eosinophilic Esophagitis Market


Market Overview:

Eosinophilic esophagitis is a chronic immune/antigen-mediated esophageal disease characterized clinically by symptoms related to esophageal dysfunction and histologically by eosinophil-predominant inflammation. Biologic therapy like monoclonal antibodies is an emerging and promising segment for treatment with minimal side effects.

Market key trends:
One of the key trends driving the market growth is increasing approval and availability of biologic therapy as a targeted treatment approach. Biologics are complex protein based recombinant therapeutic agents that can be used to selectively target inflammatory cascades leading to esophageal eosinophilia. Recently, dupilumab, an IL-4R alpha inhibitor, has received FDA approval for treatment of eosinophilic esophagitis based on positive clinical trial results demonstrating its efficacy and favorable safety profile.

The global Eosinophilic Esophagitis Market Growth is estimated to be valued at US$ 245.92 Mn in 2023 and is expected to exhibit a CAGR of 33.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
The global Eosinophilic Esophagitis market is dominated by the drug therapy segment. This is because drug therapy is currently the first line treatment option prescribed for eosinophilic esophagitis. Within drug therapy, topical corticosteroids form the largest sub-segment as they are effective in mitigating inflammation and symptoms. However, biologics which target specific cytokines and immune cells involved in the disease pathogenesis are expected to witness higher growth during the forecast period.

Key Takeaways
The global Eosinophilic Esophagitis market is expected to witness high growth, exhibiting 33.% CAGR over the forecast period, due to increasing prevalence of food allergies and gastrointestinal disorders.
Regional analysis
North America currently dominates the global market and is expected to remain the highest revenue generating region during the forecast period. This is attributed to increasing diagnosis rates, rising awareness about the disease, and strong presence of key players in the region. Asia Pacific is anticipated to witness fastest growth rate during the forecast period owing to growing health expenditures, rise in patient population, and increasing initiatives to spread awareness regarding eosinophilic esophagitis in the region.
Key players
Key players operating in the Eosinophilic Esophagitis market are Ellodi Pharmaceuticals, EsoCap AG, GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Cipla Limited, Sun Pharmaceutical Industries Limited, AstraZeneca Plc, Sanofi S.A., Arena Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Revolo Biotherapeutics, Allakos Inc., Bristol-Myers Squibb Co, Calypso Biotech, DBV Technologies, Landos Biopharma, Inc., Glenmark Pharmaceuticals, Alkem Laboratories Ltd., Quorum Innovations LLC, and Dr. Falk Pharma GmbH.


Comments

Post a Comment

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Image
Agricultural Micronutrients Market Agricultural micronutrients are essential plant nutrients required in small quantities for healthy plant growth and development. Micronutrients such as iron, zinc, manganese, molybdenum, and boron play vital roles in various metabolic functions of crops such as photosynthesis, nitrogen fixation, and enzyme activity. The increasing need to boost crop yields and improve soil fertility has raised the demand for micronutrient fertilizers globally. The growing population and reducing arable land have fueled the need for sustainable agricultural practices, propelling the micronutrients market. The global Agricultural Micronutrients Market is estimated to be valued at US$ 5.19 Bn in 2024 and is expected to exhibit a CAGR of 27.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing adoption of precision farming and digital technologies in the agriculture sector is
Read more

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Image
Dairy Alternative Market Market Overview: Dairy alternative products are gaining significant popularity due to their numerous advantages. These products are plant-based, making them suitable for individuals with lactose intolerance or those following a vegan diet. They offer similar nutritional benefits as traditional dairy products such as milk, cheese, and yogurt, while also addressing concerns related to animal welfare and environmental sustainability. The growing demand for dairy alternative products among health-conscious consumers is driving market growth. Market Key Trends: One key trend observed in the dairy alternative market is the increasing preference for plant-based milk substitutes. Plant-based milk alternatives such as almond milk, soy milk, and oat milk, among others, are gaining traction among consumers as a healthier and more sustainable option compared to traditional dairy milk. These plant-based milk alternatives offer various benefits such as being lactose-free, c
Read more

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries

Image
Antimicrobial Additives Market Antimicrobial additives are extensively used in a wide range of end-use industries such as healthcare, packaging, food and beverage, construction, and automotive. These additives help protect various materials from microorganisms such as bacteria, viruses, etc. Some key applications of antimicrobial additives include packaging of food, medical devices, fabrics, flooring, coatings, etc. The ongoing COVID-19 pandemic has further increased the importance of hygiene and sanitation, driving demand for antimicrobial materials from various sectors. The global Antimicrobial Additives Market is estimated to be valued at US$ 3.47 Bn in 2024 and is expected to exhibit a CAGR of 25.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key drivers of the market's growth is the rising demand for antimicrobial additives from the packaging industry. Packaging manufacturers
Read more